Have mental health apps lived up to their promise to offer tailored support in a challenging public health context? The answer is mixed.
Academic rigor, journalistic flair
Articles on NICE
Displaying 1 - 20 of 22 articles
Decolonising medicine will create a fairer healthcare system for all.
A new Nice guidance suggests exercise, talk therapy and acupuncture to treat chronic pain. Where does this leave those dependent on painkillers?
NHS drug budgets could rise by billions of pounds a year after a US-UK trade deal.
One in 20 patients referred to a cancer specialist by their GP don’t turn up.
NICE has concluded that more research is needed before it can recommend the use of cannabis based products for medicinal use.
Front line professionals need more support and time.
New findings show what the public really thinks about how we prioritise treatments at the end of people’s lives.
An increasing list of rare diseases can now be treated with gene therapy. But we need to figure out a way to make them affordable.
It’s time we considered the long-term benefits of community weight loss programmes to both individuals and society.
We can’t keep blaming the MMR-autism scare – there are other forces at play.
There is conflicting medical evidence.
Talking therapy for people with post-traumatic stress disorder is one suggestion. A new study finds that surfing may be beneficial too.
The Alzheimer’s Society is concerned that people with dementia aren’t getting diagnosed soon enough. But there are pros and cons to an early diagnosis.
It’s not easy to make good food choices when there’s a takeaway on every corner.
The cost of cancer drugs is killing patients and it needs to stop
NICE recommends psychotherapy for treating schizophrenia and bipolar disorder,
despite a lack of high quality evidence to show that they’re effective.
There are pros and cons to HRT. Whether or not to use it comes down to personal choice.
Hope, fear, and desperation, along with the unique characteristics of the cancer drug market, create a “perfect storm” that continues to drive up prices for cancer drugs.
The National Institute for Health and Care Excellence (NICE) has published new draft proposals laying out major changes to the way it assesses whether new medicines offer value for money for the NHS. These…
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor, Nottingham Trent University
-
Associate Professor in Cellular and Molecular Sciences, Northumbria University, Newcastle
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Associate professor, Queensland University of Technology
-
Research Fellow, Health Economics, Glasgow Caledonian University
-
Senior Investigator Scientist, University of Cambridge
-
Professor of epidemiology, University of Oxford
-
Professor of Bioethics, Macquarie University
-
Career Development Fellow (Post-doctoral Research Associate), University of Cambridge
-
Senior lecturer in Immunology, University of Exeter
-
Senior Research Fellow, Psychiatry, Psychology and Neuroscience, King's College London
-
Senior Research Fellow at Veterans and Families Institute, Anglia Ruskin University
-
Associate Professor, Washington State University
-
Professor of Molecular Oncology, University of Bradford
